Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Janette Priefert
Manager, Clinical Data
COM - Phoenix Internal Medicine
Overview
Research
More
Collaboration
(20)
Garrett Grischo
Mutual work: 4 Grants﹒4 Proposals
Collaboration Details
Roderick Tung
Mutual work: 1 Proposal
Collaboration Details
Joyce Lee-Iannotti
Mutual work: 4 Grants
Collaboration Details
Heidi Erickson
Mutual work: 4 Proposals﹒4 Grants
Collaboration Details
Mrinalini Kala
Mutual work: 4 Grants﹒4 Proposals
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(8)
RECOVER-NEURO: A Platform Protocol for Evaluation of Interventions for Cognitive Dysfunction in Post-Acute Sequelae of SARSCoV- 2 Infection (PASC)
Active
·
2023
·
$0 / $729.8K
·
External
undefined (CD)
neurology,
cognitive dysfunction,
intervention evaluation,
post-acute sequelae,
sars-cov-2 infection
RECOVER-NEURO: A Platform Protocol for Evaluation of Interventions for Cognitive Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2023
·
$0 / $5K
·
External
undefined (CD)
neuroscience,
cognitive dysfunction,
sars-cov-2,
intervention,
evaluation
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SPR00l (Tildacerfont) in Reducing Supraphysiologic Glucocorticoid Use in Adult Subjects with Classic Congeni
Active
·
2022
·
$0 / $277.2K
·
External
undefined (CD)
glucocorticoid reduction,
adult subjects
Novel 2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
Active
·
2022
·
$0 / $71.4K
·
External
undefined (CD)
thrombosis,
antiplasmin,
clinical trial,
intravascular,
lysis
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Adult Subjects with Classic Congenital Adrenal Hyperplasia
Active
·
2022
·
$0 / $56.4K
·
External
undefined (CD)
adrenal hyperplasia,
clinical trial,
drug efficacy,
safety evaluation,
dose-ranging
Page 1 of 2
Previous page
Next page